Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor

RETRACTED: Regulatory roles of epigenetic modulators, modifiers and mediators in lung cancer

(2017) Lin Shi et al.   SEMINARS IN CANCER BIOLOGY

Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448

(2016) Oluwaseun Adebayo Bamodu et al.   BMC CANCER

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Lung cancer stem cells: The root of resistance

(2016) Lauren MacDonagh et al.   CANCER LETTERS

The cancer stem-cell signaling network and resistance to therapy

(2016) A. Carnero et al.   CANCER TREATMENT REVIEWS

Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX

(2016) Kelly Marie Arcipowski et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016

(2016) Daniel S.W. Tan et al.   Journal of Thoracic Oncology

An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells

(2016) Maia Vinogradova et al.   Nature Chemical Biology

Cancer stem cells and chemoresistance: The smartest survives the raid

(2016) Jihe Zhao   PHARMACOLOGY & THERAPEUTICS

Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression

(2016) Kazumasa Komura et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells

(2015) Norashikin Zakaria et al.   BMC CANCER

Epigenetics in lung cancer diagnosis and therapy

(2015) Aditi Mehta et al.   CANCER AND METASTASIS REVIEWS

Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma

(2015) Chun-Shu Lin et al.   CANCER LETTERS

Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells

(2015) Inna Zubrilov et al.   CANCER LETTERS

Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases

(2015) John R. Horton et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5+ liver cancer initiating cells by suppressing negative regulators of β-catenin signaling

(2015) Z-J Lei et al.   ONCOGENE

PLU-1/JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma

(2015) ZHIBIN CUI et al.   ONCOLOGY REPORTS

Targeting histone lysine methylation in cancer

(2015) John McGrath et al.   PHARMACOLOGY & THERAPEUTICS

Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer

(2015) Lishuang Wang et al.   TUMOR BIOLOGY

JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer

(2014) Shoji Yamamoto et al.   CANCER CELL

Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes

(2014) Hyang Sook Seol et al.   CANCER LETTERS

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

The KDM5 family of histone demethylases as targets in oncology drug discovery

(2014) Peter Birk Rasmussen et al.   Epigenomics

Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells

(2013) Alexander Roesch et al.   CANCER CELL

Inhibition of Histone Demethylase JMJD1A Improves Anti-Angiogenic Therapy and Reduces Tumor-Associated Macrophages

(2013) T. Osawa et al.   CANCER RESEARCH

EGF Receptor Activates MET through MAPK to Enhance Non-Small Cell Lung Carcinoma Invasion and Brain Metastasis

(2013) J. L. Breindel et al.   CANCER RESEARCH

SOX2 regulates apoptosis through MAP4K4-Survivin signaling pathway in human lung cancer cells

(2013) Si Chen et al.   CARCINOGENESIS

Identification of Small Molecule Inhibitors of Jumonji AT-rich Interactive Domain 1B (JARID1B) Histone Demethylase by a Sensitive High Throughput Screen

(2013) Joyce Sayegh et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Lung cancer stem cells: Molecular features and therapeutic targets

(2013) Sandeep Singh et al.   MOLECULAR ASPECTS OF MEDICINE

Cancer treatment and survivorship statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer Epigenetics: From Mechanism to Therapy

(2012) Mark A. Dawson et al.   CELL

Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor

(2012) Line H. Kristensen et al.   FEBS Journal

Cancer stem cells and epithelial–mesenchymal transition: Concepts and molecular links

(2012) Christina Scheel et al.   SEMINARS IN CANCER BIOLOGY

HGF-independent potentiation of EGFR action by c-Met

(2011) A M Dulak et al.   ONCOGENE

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

(2009) Christopher G. Azzoli et al.   JOURNAL OF CLINICAL ONCOLOGY